7-hydroxymitragynine (7-OH) is the most potent naturally occurring opioid-receptor-active compound found in any plant. A 2016 study in the Journal of Medicinal Chemistry found 7-OH is approximately 13 times more potent than morphine at mu-opioid receptors in binding assays. For context: morphine is the reference standard of opioid potency. Fentanyl is 50–100x more potent than morphine. 7-OH sits between morphine and fentanyl in receptor binding potency. However, 7-OH naturally occurs at less than 2% of total kratom alkaloids, so standard kratom powder delivers very small absolute doses of 7-OH. Concentrated 7-OH extracts change this equation dramatically — they deliver meaningful opioid-potency effects at small volumes.

Why is 7-OH so much stronger than kratom powder?

The potency difference is purely concentration. Standard kratom powder is 60–70% mitragynine and less than 2% 7-OH. Mitragynine is a partial mu-opioid agonist with adrenergic effects; it's the primary compound responsible for kratom's energy and mood effects. 7-OH is a full mu-opioid agonist at higher concentrations — the compound responsible for kratom's strongest pain relief, sedation, and euphoria. When you consume 5g of kratom powder, you're getting approximately 0.1g or less of 7-OH — trace amounts. A concentrated 7-OH extract can deliver 25mg or more in a single dose. This is the entire potency differential.

How does 7-OH potency compare to pharmaceutical opioids?

In receptor binding assays, 7-OH at ~13x morphine potency places it roughly comparable to hydromorphone (Dilaudid, 5–10x morphine) or between morphine and oxycodone in clinically experienced potency. This does not mean 7-OH products produce effects identical to pharmaceutical opioids — the pharmacokinetic profiles, bioavailability, and route of administration differ significantly. Oral 7-OH bioavailability is variable; pharmaceutical opioids have well-characterized and consistent pharmacokinetics. The practical message: treat 7-OH products with the same caution you'd apply to a mid-range prescription opioid.

What risks does 7-OH's potency create?

The primary risks of 7-OH's potency: (1) Narrow therapeutic window — the dose range between desired effects and uncomfortable side effects (nausea, respiratory depression at very high doses) is narrower than for kratom powder. (2) Faster tolerance and dependency development than standard kratom. (3) Stronger withdrawal syndrome upon cessation. (4) Higher risk of adverse effects in users who are opioid-naive or who combine with other CNS depressants. 7-OH products should be used conservatively, at minimum effective dose, no more frequently than necessary, and should never be combined with alcohol or benzodiazepines. Find 7-OH and kratom products at Elevated Haze.